The Role of Inflammation and COX-Derived Prostanoids in the Effects of Bradykinin on Isolated Rat Aorta and Urinary Bladder
Authors:
- 3 May 2011
- journal article
- Published by Springer Nature in Inflammation
- Vol. 35 (2) , 420-428
Abstract
Bradykinin, a vasoactive peptide, increases during inflammation and induces the formation of prostaglandins through specific receptor activation. Two types of receptors mediate the biological effects of bradykinin, B1 and B2 receptors. Although B2 receptors are present in most tissues, B1 receptors are expressed after inflammatory stimuli or tissue injury. Bradykinin has a high affinity for B2 and a low affinity for B1 receptors, whereas the opposite occurs for des-Arg9-bradykinin. Recently, it has been reported that nonsteroidal anti-inflammatory drugs have different inhibitory activities on cyclooxygenase isozymes, COX-1, COX-2, and COX-3. In the present study, we have investigated the contributions of different COX isozyme inhibitions and inflammation on bradykinin-induced effects of isolated rat aorta and urinary bladder smooth muscle contractions. Male Sprague–Dawley rats weighing 200–250 g were used in the study. The vasodilatory responses to bradykinin (1 nM–1 μM) were studied on isolated rat aorta rings contracted with norepinephrine (0.1 μM) following incubation with dipyrone (100, 700, and 2,000 μM). The relaxant responses of dipyrone (100, 700, and 2,000 μM) were also compared on the isolated rat urinary bladder contracted with bradykinin (n = 8). A bacterial lipopolysaccharide was used for the induction of inflammation (n = 8). The levels of PGE2, PGF1α, TXB2, nitric oxide synthase (NOS), IL-10, and TNF-α were all determined in both the plasma and the perfusate of the aorta preparations (n = 5). The vasodilatory activities of bradykinin and des-Arg9-bradykinin were significantly increased upon the inhibition of COX-3 (dipyrone at 100 μM). These effects disappeared in the inflamed group. PGE2, PGF1α, and TXB2 were significantly high, but NOS activity was low in the aorta perfusate after the inhibition of COX-3. Dipyrone showed the relaxant activity of the urinary bladder contracted with bradykinin. The vasodilatory activity of des-Arg9-bradykinin was in the inflamed group but not in the non-inflamed group. Bradykinin did not contract urinary bladder in inflamed group. The results suggest that COX-induced products may play an important role in the bradykinin-induced rat aortic smooth muscle relaxations.Keywords
This publication has 41 references indexed in Scilit:
- Angiotensin II Chronic Infusion Induces B1 Receptor Expression in Aorta of RatsHypertension, 2007
- Functional characterization of the mechanisms underlying bradykinin-induced relaxation in the isolated rat carotid arteryLife Sciences, 2007
- Bradykinin potentiates cytokine‐induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expressionArthritis & Rheumatism, 2007
- Pharmacodynamic of cyclooxygenase inhibitors in humansProstaglandins & Other Lipid Mediators, 2007
- Mechanisms underlying the relaxation response induced by bradykinin in the epithelium‐intact guinea‐pig trachea in vitroBritish Journal of Pharmacology, 2005
- Cyclooxygenases 1, 2, and 3 and the Production of Prostaglandin I2: Investigating the Activities of Acetaminophen and Cyclooxygenase-2-Selective Inhibitors in Rat TissuesThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Mechanisms Mediating the Vasoactive Effects of the B 1 Receptors of BradykininHypertension, 2003
- Glucocorticoid-Mediated Suppression of the Promoter Activity of the Cyclooxygenase-2 Gene Is Modulated by Expression of Its Receptor in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Bradykinin receptorsGeneral Pharmacology: The Vascular System, 1997